Since its approval in 2019, treatment with Trikafta has markedly reduced the number of lung transplants among people in…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
People with cystic fibrosis-related diabetes (CFRD) have lower pancreatic production of the GLP-1 receptor (GLP-1R), a protein that binds…
A more rapid decline in lung function in people with cystic fibrosis (CF) has been linked in a new…
Although parents of children with cystic fibrosis (CF) recognize the benefits of their children getting physical activity in schools,…
Chronic infection with the hepatitis E virus (HEV) may be linked to pig-derived pancreatic enzyme replacement therapy (PERT) in…
People with cystic fibrosis (CF) experience a more severe disease course when they continue to have a small hole…
More gastroenterologists with expertise in cystic fibrosis (CF) are needed alongside registered dietitians to provide comprehensive patient care, a…
The immune system of people with cystic fibrosis (CF) might be impaired due to long-term persistent lung infections and…
The balance of acids and bases in the urine of people with cystic fibrosis (CF) reflects lung and pancreas…
A Phase 1b study that’s evaluating the safety of RCT2100, ReCode Therapeutics‘ investigational genetic medicine for people with…